Apolipoprotein E Arg136 → Cys in individuals with premature myocardial infarction

Folia Biologica

Volumn 55, Issue 3, 2009, Pages 116-118

  Hubáček, Jaroslav A ^a,b,c   Poledne, R ^a,b   Pitha J ^a,b   Aschermann, M ^d   Skalicka H ^d   Stanek V ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b Cardiovascular Research Center   (Czech Republic)

^c UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Apolipoprotein E; Mutation; Myocardial infarction; Plasma cholesterol; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; ARGININE; CYSTEINE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; FEMALE; GENE MUTATION; HEART INFARCTION; HUMAN; MALE; OBESITY; SMOKING;

EID: 67650360421     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Davignon, J., Gregg, R. E., Sing, C. F. (1988) Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 8, 1-21.
2. Feussner, G., Albanese, M., Mann, W. A., Valencia, A., Schuster, H. (1996) Apolipoprotein E2 (Arg136→Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia. Eur. J. Clin. Invest. 26, 13-23.
3. Gerdes, L. U., Klausen, I. C., Sihn, I., Faergeman, O. (1992) Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study population around the world. Genet. Epidemiol. 9, 155-167.
4. Hixson, J. E., Vernier, D. T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31, 545-548. (Pubitemid 20107994)
5. Hubacek, J. A., Pitha, J., Stávek, P., Poledne, R. (2000) Variable expression of hypercholesterolemia in apolipoprotein E2* (Arg136→Cys) heterozygotes. Physiol. Res. 49, 307-314.
6. Hubacek, J. A., Pitha, J., Skodova, Z., Poledne, R. (2002) Rare variant of apolipoprotein E (Arg136→Cys) in a subject with normal lipid values. Physiol Res. 51, 107-108. (Pubitemid 34266450)
7. Hubacek, J. A., Adamkova, V., Skodova, Z. (2005) Rare variant of apolipoprotein E (Arg136→Ser) in two normolipidemic individuals. Physiol. Res. 54, 573-575.
8. Hubacek, J. A., Adamkova, V., Stavek, P., Kubinova, R., Peasey, A., Pikhart, H., Marmot, M., Bobak, M. (2008) Apolipoprotein E Arg136→Cys mutation and hyperlipidemia in a large central European population sample. Clin. Chim. Acta 388, 217-218.
9. 136→ Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia. J. Lipid Res. 39, 658-669. (Pubitemid 28158407)
10. Miller, S. A., Dykes, D. D., Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
11. Minnich, A., Weisgraber, K. H., Newhouse, Y., Dong, L. M., Fortin, L. J., Tremblay, M., Davignon, J. (1995) Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3′ (Arg136→His): association with mild dyslipidemia and double pre-β very low density lipoproteins. J. Lipid Res. 36, 57-66.
12. Pocovi, M., Cenarro, A., Civiera, F., Myers, R. H., Casao, E., Esteban, M., Ordovas, J. M. (1996) Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E (Arg136→Ser) variant in multigenerational pedigree studies. Atherosclerosis 122, 33-46. (Pubitemid 26135189)
13. Svobodova, H., Kucera, F., Stulc, T., Vrablik, M., Amartuvshin, B., Altannavch, T. S., Ceska, R. (2007) Apolipoprotein E gene polymorphism in the Mongolian population. Folia Biol. (Praha) 53, 138-142.
14. Talmud, P. J., Stephens, J. W., Hawe, E., Demissie, S., Cupples, L. A., Hurel, S. J., Humphries, S. E., Ordovas, J. M. (2005) The significant increase in cardiovascular disease risk in APOEε4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann. Hum. Genet. 69, 613-622.
15. Walden, C. C., Huff, M. W., Leiter, L. A., Connelly, P. W., Hegele, A. (1994) Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping. J. Clin. Endocrinol. Metab. 78, 699-704.
16. Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., Agard, D. A. (1991). Three-dimensional structure of the LDL-receptor-binding domain apolipoprotein E. Science 252, 1817-1822. (Pubitemid 21917100)